Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 29 Sept 2026 for Phio Pharmaceuticals Corp..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Lisa Cabott Carson: trading record in brief
Lisa Cabott Carson is a declared insider of Phio Pharmaceuticals Corp., with filings sourced from SEC (Form 4). We count 4 filings; the first trade dates from 11 September 2025 and the latest from 28 September 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 29 September 2026: a share grant, in Phio Pharmaceuticals Corp. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Lisa Cabott Carson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
108,000 shares0Common Stock, $.0001 par valueSEC:0001683168-26-007481:0
12,888 shares@ US$1.030.11% mcap100.0% of flowCommon Stock, $.0001 par valueSEC:0001683168-26-007158:0
47,000 shares0Common Stock, $.0001 par valueSEC:0001683168-26-000807:0
47,000 shares0Common Stock, $.0001 par valueSEC:0001683168-25-006956:0
4 of 4 declarations
